S

Sensei Biotherapeutics
D

SNSE

11.400
USD
-0.22
(-1.85%)
مغلق
حجم التداول
0
الربح لكل سهم
-16
العائد الربحي
-
P/E
-1
حجم السوق
14,378,706
المقالات

العنوان: Sensei Biotherapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).